Literature DB >> 17566141

Interval estimation of binomial proportion in clinical trials with a two-stage design.

Wei-Yann Tsai1, Yunchan Chi, Chia-Min Chen.   

Abstract

Generally, a two-stage design is employed in Phase II clinical trials to avoid giving patients an ineffective drug. If the number of patients with significant improvement, which is a binomial response, is greater than a pre-specified value at the first stage, then another binomial response at the second stage is also observed. This paper considers interval estimation of the response probability when the second stage is allowed to continue. Two asymptotic interval estimators, Wald and score, as well as two exact interval estimators, Clopper-Pearson and Sterne, are constructed according to the two binomial responses from this two-stage design, where the binomial response at the first stage follows a truncated binomial distribution. The mean actual coverage probability and expected interval width are employed to evaluate the performance of these interval estimators. According to the comparison results, the score interval is recommended for both Simon's optimal and minimax designs. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 17566141     DOI: 10.1002/sim.2930

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  14 in total

1.  Evaluation of vaccine seroresponse rates and adverse event rates through Bayesian and frequentist methods.

Authors:  Jin Liu; Feng Chen; Feng-Cai Zhu; Jian-Ling Bai; Jing-Xin Li; Hao Yu; Pei Liu; Ping Zeng
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Mortality and Complications Following Visceral Surgery: A Nationwide Analysis Based on the Diagnostic Categories Used in German Hospital Invoicing Data.

Authors:  Philip Baum; Johannes Diers; Sven Lichthardt; Carolin Kastner; Nicolas Schlegel; Christoph-Thomas Germer; Armin Wiegering
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

3.  Exact p-values for Simon's two-stage designs in clinical trials.

Authors:  Guogen Shan; Hua Zhang; Tao Jiang; Hanna Peterson; Daniel Young; Changxing Ma
Journal:  Stat Biosci       Date:  2016-06-16

Review 4.  Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.

Authors:  Sin-Ho Jung
Journal:  Contemp Clin Trials       Date:  2015-03-03       Impact factor: 2.226

5.  Influenza-associated Hospitalization in Children Younger Than 5 Years of Age in Suzhou, China, 2011-2016.

Authors:  Jia Yu; Xiyan Zhang; Wei Shan; Junmei Gao; Jun Hua; Jianmei Tian; Yunfang Ding; Jun Zhang; Liling Chen; Ying Song; Suizan Zhou; A Danielle Iuliano; Carolyn M Greene; Tao Zhang; Genming Zhao
Journal:  Pediatr Infect Dis J       Date:  2019-05       Impact factor: 2.129

6.  Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases.

Authors:  Amit K Garg; Almon S Shiu; James Yang; Xin-Shelley Wang; Pamela Allen; Barry W Brown; Patricia Grossman; Erik K Frija; Mary Frances McAleer; Syed Azeem; Paul D Brown; Laurence D Rhines; Eric L Chang
Journal:  Cancer       Date:  2012-04-17       Impact factor: 6.860

7.  Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.

Authors:  Panayiotis Savvides; Govardhanan Nagaiah; Pierre Lavertu; Pingfu Fu; John J Wright; Robert Chapman; Jay Wasman; Afshin Dowlati; Scot C Remick
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

8.  Exact confidence limits for the response rate in two-stage designs with over- or under-enrollment in the second stage.

Authors:  Guogen Shan
Journal:  Stat Methods Med Res       Date:  2016-07-07       Impact factor: 3.021

9.  Ara h 2-specific IgE is superior to whole peanut extract-based serology or skin prick test for diagnosis of peanut allergy in infancy.

Authors:  Corinne Keet; Mihaela Plesa; Daria Szelag; Wayne Shreffler; Robert Wood; Joan Dunlop; Roger Peng; Jennifer Dantzer; Robert G Hamilton; Alkis Togias; Michael Pistiner
Journal:  J Allergy Clin Immunol       Date:  2021-01-19       Impact factor: 10.793

10.  What inference for two-stage phase II trials?

Authors:  Raphaël Porcher; Kristell Desseaux
Journal:  BMC Med Res Methodol       Date:  2012-08-06       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.